Brookfield Business Partners L.P. (BBU) Q2 2019 Earnings Call Transcript
Logo of jester cap with thought bubble.
Logo of jester cap with thought bubble.

In This Article:

Image source: The Motley Fool.

Brookfield Business Partners L.P. (NYSE: BBU)
Q2 2019 Earnings Call
Jul 31, 2019, 10:00 a.m. ET

Contents:

  • Prepared Remarks

  • Questions and Answers

  • Call Participants

Prepared Remarks:

Operator

Welcome to the Brookfield Business Partners' Second Quarter 2019 Results Conference Call and Webcast. [Operator Instructions]. After the presentation, there will be an opportunity to ask questions. [Operator Instructions]

Now I'd like to turn the conference over to Jaspreet Dehl, Chief Financial Officer. Please go ahead, Ms. Dehl.

Jaspreet Dehl -- Managing Partner and Chief Financial Officer

Thank you, operator, and good morning, everyone. Welcome to Brookfield Business Partners' 2019 Second Quarter Conference Call.

Before we begin, I'd like to remind you that in responding to questions and in talking about our growth initiatives and our financial and operating performance, we may make forward-looking statements. These statements are subject to known and unknown risks and future results may differ materially. For further information on known risk factors, I would encourage you to review our filings with the Securities Regulators in Canada and the U.S., both of which are available on our website.

I'll pass the call over to Cyrus to provide an update on our strategic initiatives. After which, I will review our financial results for the second quarter. We will then be available to take your questions.

I'll now pass the call over to Cyrus.

Cyrus Madon -- Managing Partner, CEO Private Equity

Thanks, Jaspreet. Good morning, everyone. Thanks for joining us today. We're really pleased to report that we had a great performing quarter from an operating perspective this quarter, and we also progressed many strategic initiatives.

I thought I'd start by giving an overview of our Healthscope acquisition. HealthScope is the second-largest private hospital operator in Australia and the largest pathology services provider in New Zealand. Its hospitals in Australia serve as critical social infrastructure, providing best-in-class essential services to the private sector and its pathology business is a stable business underpinned by contracts with health authorities that serve 75% of New Zealand's population.

HealthScope became the target of a hostile takeover offer and this followed underperformance of its $800 million investment program into developments, redevelopments across 18 sites, the largest of which was the Northern Beaches Hospital which is in Sydney. We saw a chance to step in, work with HealthScope's board and management to structure a superior transaction and provide a tailored solution that benefited both the company and the shareholders.